Cargando…

Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model

Cancer treatment resistance is a caused by presence of various types of cells and heterogeneity within the tumor. Tumor cell–cell and cell-microenvironment interactions play a significant role in the tumor progression and invasion, which have important implications for diagnosis, and resistance to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghimi, Nafiseh, Hosseini, Seied Ali, Dalan, Altay Burak, Mohammadrezaei, Dorsa, Goldman, Aaron, Kohandel, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444838/
https://www.ncbi.nlm.nih.gov/pubmed/37607994
http://dx.doi.org/10.1038/s41598-023-40680-x
_version_ 1785094041646399488
author Moghimi, Nafiseh
Hosseini, Seied Ali
Dalan, Altay Burak
Mohammadrezaei, Dorsa
Goldman, Aaron
Kohandel, Mohammad
author_facet Moghimi, Nafiseh
Hosseini, Seied Ali
Dalan, Altay Burak
Mohammadrezaei, Dorsa
Goldman, Aaron
Kohandel, Mohammad
author_sort Moghimi, Nafiseh
collection PubMed
description Cancer treatment resistance is a caused by presence of various types of cells and heterogeneity within the tumor. Tumor cell–cell and cell-microenvironment interactions play a significant role in the tumor progression and invasion, which have important implications for diagnosis, and resistance to chemotherapy. In this study, we develop 3D bioprinted in vitro models of the breast cancer tumor microenvironment made of co-cultured cells distributed in a hydrogel matrix with controlled architecture to model tumor heterogeneity. We hypothesize that the tumor could be represented by a cancer cell-laden co-culture hydrogel construct, whereas its microenvironment can be modeled in a microfluidic chip capable of producing a chemical gradient. Breast cancer cells (MCF7 and MDA-MB-231) and non-tumorigenic mammary epithelial cells (MCF10A) were embedded in the alginate-gelatine hydrogels and printed using a multi-cartridge extrusion bioprinter. Our approach allows for precise control over position and arrangements of cells in a co-culture system, enabling the design of various tumor architectures. We created samples with two different types of cells at specific initial locations, where the density of each cell type was carefully controlled. The cells were either randomly mixed or positioned in sequential layers to create cellular heterogeneity. To study cell migration toward chemoattractant, we developed a chemical microenvironment in a chamber with a gradual chemical gradient. As a proof of concept, we studied different migration patterns of MDA-MB-231 cells toward the epithelial growth factor gradient in presence of MCF10A cells in different ratios using this device. Our approach involves the integration of 3D bioprinting and microfluidic devices to create diverse tumor architectures that are representative of those found in various patients. This provides an excellent tool for studying the behavior of cancer cells with high spatial and temporal resolution.
format Online
Article
Text
id pubmed-10444838
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104448382023-08-24 Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model Moghimi, Nafiseh Hosseini, Seied Ali Dalan, Altay Burak Mohammadrezaei, Dorsa Goldman, Aaron Kohandel, Mohammad Sci Rep Article Cancer treatment resistance is a caused by presence of various types of cells and heterogeneity within the tumor. Tumor cell–cell and cell-microenvironment interactions play a significant role in the tumor progression and invasion, which have important implications for diagnosis, and resistance to chemotherapy. In this study, we develop 3D bioprinted in vitro models of the breast cancer tumor microenvironment made of co-cultured cells distributed in a hydrogel matrix with controlled architecture to model tumor heterogeneity. We hypothesize that the tumor could be represented by a cancer cell-laden co-culture hydrogel construct, whereas its microenvironment can be modeled in a microfluidic chip capable of producing a chemical gradient. Breast cancer cells (MCF7 and MDA-MB-231) and non-tumorigenic mammary epithelial cells (MCF10A) were embedded in the alginate-gelatine hydrogels and printed using a multi-cartridge extrusion bioprinter. Our approach allows for precise control over position and arrangements of cells in a co-culture system, enabling the design of various tumor architectures. We created samples with two different types of cells at specific initial locations, where the density of each cell type was carefully controlled. The cells were either randomly mixed or positioned in sequential layers to create cellular heterogeneity. To study cell migration toward chemoattractant, we developed a chemical microenvironment in a chamber with a gradual chemical gradient. As a proof of concept, we studied different migration patterns of MDA-MB-231 cells toward the epithelial growth factor gradient in presence of MCF10A cells in different ratios using this device. Our approach involves the integration of 3D bioprinting and microfluidic devices to create diverse tumor architectures that are representative of those found in various patients. This provides an excellent tool for studying the behavior of cancer cells with high spatial and temporal resolution. Nature Publishing Group UK 2023-08-22 /pmc/articles/PMC10444838/ /pubmed/37607994 http://dx.doi.org/10.1038/s41598-023-40680-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Moghimi, Nafiseh
Hosseini, Seied Ali
Dalan, Altay Burak
Mohammadrezaei, Dorsa
Goldman, Aaron
Kohandel, Mohammad
Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
title Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
title_full Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
title_fullStr Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
title_full_unstemmed Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
title_short Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
title_sort controlled tumor heterogeneity in a co-culture system by 3d bio-printed tumor-on-chip model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444838/
https://www.ncbi.nlm.nih.gov/pubmed/37607994
http://dx.doi.org/10.1038/s41598-023-40680-x
work_keys_str_mv AT moghiminafiseh controlledtumorheterogeneityinacoculturesystemby3dbioprintedtumoronchipmodel
AT hosseiniseiedali controlledtumorheterogeneityinacoculturesystemby3dbioprintedtumoronchipmodel
AT dalanaltayburak controlledtumorheterogeneityinacoculturesystemby3dbioprintedtumoronchipmodel
AT mohammadrezaeidorsa controlledtumorheterogeneityinacoculturesystemby3dbioprintedtumoronchipmodel
AT goldmanaaron controlledtumorheterogeneityinacoculturesystemby3dbioprintedtumoronchipmodel
AT kohandelmohammad controlledtumorheterogeneityinacoculturesystemby3dbioprintedtumoronchipmodel